Therefore, we next investigated if genes hypermethylated in their regulatory region could be enriched among anti-oncogenic pathways, which could suggest a potential inhibition of those pathways leading to the pro-oncogenic phenotype we have previously observed in GLO1-depleted breast cancer cells [4, 6]. This evidence concerns the gene GLO1 and breast carcinoma.